Avik Dutta
Research Subjects
Avik Dutta has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Alindam Ghosh
Department of Pharmaceutical Science, DmbH Institute of Medical Science, Hooghly, West Bengal, India
2 shared publications - Faruk Alam
Faculty of Pharmaceutical Science, Assam down town University, Sankar Madhab Path, Gandhi Nagar, Panikhaiti, Guwahati, Assam, 781026, India
2 shared publications - Surabhi Mandal
Himalayan Pharmacy Institute, Majitar, Rongpo, Sikkim, India
2 shared publications - Amrit Kumar Rath
Faculty of Pharmaceutical Science, Assam Downtown University, Sankar Madhab Path,Gandhi Nagar, Panikhaiti, Guwahati, Assam, 781026, India
1 shared publication - Bhupendra Shrestha
Himalayan Pharmacy Institute East Sikkim India
1 shared publication - Durgaprasad Kemisetti
Faculty of Pharmaceutical Science, Assam down town University, Sankar Madhab Path, Gandhi Nagar, Panikhaiti, Guwahati, Assam, 781026, India
1 shared publication
Latest Publications
- Open Access
- 27 October 2025
- Published by Asian Publication Corporation in Asian Journal of Chemistry
- Vol. 37 (11) , 2617-2630
Eco-Compatible Synthesis of Metal Nanoparticles: Influencing Parameters, Characterization, Advancement and Applications
The field of nanotechnology continues to offer profound implications across biomedical, environmental and materials science domains with metallic nanoparticles (MNPs) at the forefront due to their size-dependent physical and chemical attributes. This review provides a critical evaluation of the biosynthesis of MNPs particularly gold (AuNPs) and silver nanoparticles (AgNPs) employing plant-derived phytochemicals and microbial metabolites as reducing and stabilizing agents. The biosynthetic route is compared against conventional top-down and bottom-up methods, with specific attention to the influence of synthesis parameters (e.g. pH, temperature, extract concentration) on nanoparticle morphology, yield and surface chemistry. The unique optical and surface plasmon resonance properties of noble metals are discussed in the context of their biomedical applications, notably in antimicrobial coatings, cancer therapeutics, drug delivery vectors and diagnostic platforms. Moreover, functional nanoparticles of other metals (Pd, Cu, Fe, Fe3O4, α-Fe2O4, and nZVI) are examined for their roles in catalysis, pollutant degradation and water treatment. The review also delineates analytical techniques employed in nanoparticle characterization, encompassing structural, compositional, and surface profiling. Finally, the clinical relevance and translational potential of green-synthesized MNPs are contextualized within the broader framework of sustainable nanomaterials development.
- 27 October 2025
- Published by Asian Publication Corporation in Asian Journal of Chemistry
- Vol. 37 (11) , 2617-2630
Open AccessEco-Compatible Synthesis of Metal Nanoparticles: Influencing Parameters, Characterization, Advancement and Applications
The field of nanotechnology continues to offer profound implications across biomedical, environmental and materials science domains with metallic nanoparticles (MNPs) at the forefront due to their size-dependent physical and chemical attributes. This review provides a critical evaluation of the biosynthesis of MNPs particularly gold (AuNPs) and silver nanoparticles (AgNPs) employing plant-derived phytochemicals and microbial metabolites as reducing and stabilizing agents. The biosynthetic route is compared against conventional top-down and bottom-up methods, with specific attention to the influence of synthesis parameters (e.g. pH, temperature, extract concentration) on nanoparticle morphology, yield and surface chemistry. The unique optical and surface plasmon resonance properties of noble metals are discussed in the context of their biomedical applications, notably in antimicrobial coatings, cancer therapeutics, drug delivery vectors and diagnostic platforms. Moreover, functional nanoparticles of other metals (Pd, Cu, Fe, Fe3O4, α-Fe2O4, and nZVI) are examined for their roles in catalysis, pollutant degradation and water treatment. The review also delineates analytical techniques employed in nanoparticle characterization, encompassing structural, compositional, and surface profiling. Finally, the clinical relevance and translational potential of green-synthesized MNPs are contextualized within the broader framework of sustainable nanomaterials development.
- 20 October 2025
- Published by Bentham Science Publishers Ltd. in Pharmaceutical Nanotechnology
- Vol. 13, 1-18
Advancements in Carbon Nanotube-based Drug Delivery Systems: Innovations, Challenges, and Future Directions
Carbon nanotubes (CNTs) have emerged as extremely promising nanocarriers for drug delivery due to their superior structural, mechanical, and electrical capabilities. This study digs into recent advances in CNT-based drug delivery systems, focusing on novel functionalization strategies, hybrid nanostructures, and customized nanocarrier designs. Functionalization using polymers, peptides, and other bioactive compounds has dramatically improved CNT solubility, biocompatibility, and precise targeting. Furthermore, hybrid nanostructures that combine CNTs with nanoparticles, liposomes, or metallic components have higher drug-loading capacities, multifunctional therapeutic effectiveness, and controlled drug-release features. CNTs may be customized in size, shape, and surface chemistry, allowing for the development of precise delivery systems that are particularly useful in cancer and complicated disease therapy. However, despite these advances, cytotoxicity, regulatory limits, and difficulty with large-scale manufacturing impede clinical translation. Sustainable methods, thorough safety assessments, and advanced technology like artificial intelligence to maximize functionality and design are all necessary to overcome these obstacles. Future research should focus on overcoming these hurdles to fully realize CNTs' potential as flexible, effective, and safe nanocarriers in drug delivery applications.
- 20 October 2025
- Published by Bentham Science Publishers Ltd. in Pharmaceutical Nanotechnology
- Vol. 13, 1-18
Advancements in Carbon Nanotube-based Drug Delivery Systems: Innovations, Challenges, and Future Directions
Carbon nanotubes (CNTs) have emerged as extremely promising nanocarriers for drug delivery due to their superior structural, mechanical, and electrical capabilities. This study digs into recent advances in CNT-based drug delivery systems, focusing on novel functionalization strategies, hybrid nanostructures, and customized nanocarrier designs. Functionalization using polymers, peptides, and other bioactive compounds has dramatically improved CNT solubility, biocompatibility, and precise targeting. Furthermore, hybrid nanostructures that combine CNTs with nanoparticles, liposomes, or metallic components have higher drug-loading capacities, multifunctional therapeutic effectiveness, and controlled drug-release features. CNTs may be customized in size, shape, and surface chemistry, allowing for the development of precise delivery systems that are particularly useful in cancer and complicated disease therapy. However, despite these advances, cytotoxicity, regulatory limits, and difficulty with large-scale manufacturing impede clinical translation. Sustainable methods, thorough safety assessments, and advanced technology like artificial intelligence to maximize functionality and design are all necessary to overcome these obstacles. Future research should focus on overcoming these hurdles to fully realize CNTs' potential as flexible, effective, and safe nanocarriers in drug delivery applications.